MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

A Study of AdCh63 AMA1 Alone and With MVA AMA1

Phase 1
Completed
Conditions
Malaria
Interventions
Biological: AdCh63 AMA1
Biological: AdCh63 AMa1 and MVA AMA1
First Posted Date
2010-03-29
Last Posted Date
2011-03-28
Lead Sponsor
University of Oxford
Target Recruit Count
16
Registration Number
NCT01095055
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Old Road, Headington, Oxford, United Kingdom

🇬🇧

Hospital for Tropical Diseases, London, United Kingdom

Aripiprazole and Prolactin Study

Phase 4
Completed
Conditions
Hyperprolactinemia
First Posted Date
2010-03-11
Last Posted Date
2015-05-28
Lead Sponsor
University of Oxford
Target Recruit Count
15
Registration Number
NCT01085383
Locations
🇬🇧

University Dept. of Psychiatry, Oxford, Oxfordshire, United Kingdom

Extending the National Health Service (NHS) Breast Screening Age Range

Not Applicable
Active, not recruiting
Conditions
Breast Cancer Mortality
Interventions
Other: Invitation for breast screening
First Posted Date
2010-03-05
Last Posted Date
2023-01-09
Lead Sponsor
University of Oxford
Target Recruit Count
4000000
Registration Number
NCT01081288
Locations
🇬🇧

Cancer Epidemiology Unit, Richard Doll Building, University of Oxford, Roosevelt Drive, Oxford, United Kingdom

Incidence of Vivax Along the Thai Burma Border

Not Applicable
Completed
Conditions
Vivax Malaria
Interventions
First Posted Date
2010-02-26
Last Posted Date
2023-01-17
Lead Sponsor
University of Oxford
Target Recruit Count
403
Registration Number
NCT01076868
Locations
🇹🇭

Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Study on the Treatment of Vivax Malaria

Phase 3
Completed
Conditions
Vivax Malaria
Interventions
Drug: Chloroquine/Primaquine
First Posted Date
2010-02-24
Last Posted Date
2013-08-28
Lead Sponsor
University of Oxford
Target Recruit Count
655
Registration Number
NCT01074905
Locations
🇹🇭

Shoklo Malaria Research Unit, Mae Sot, Thailand

American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis

Conditions
Polyarteritis Nodosa
Churg Strauss Syndrome
Wegener's Granulomatosis
Microscopic Polyangiitis
Giant Cell Arteritis
Takayasu Arteritis
First Posted Date
2010-02-10
Last Posted Date
2016-08-19
Lead Sponsor
University of Oxford
Target Recruit Count
3588
Registration Number
NCT01066208
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Cedars-Sinai Medical Center, LA, Los Angeles, California, United States

🇺🇸

University of California, San Francisco, San Francisco, California, United States

and more 117 locations

The DHA (Docosahexaenoic Acid) Oxford Learning and Behaviour (DOLAB) Study

Phase 2
Completed
Conditions
Learning
Behaviour
Interventions
Dietary Supplement: DHA (docosahexaenoic acid)
Dietary Supplement: Sunflower oil capsules
First Posted Date
2010-02-10
Last Posted Date
2011-10-28
Lead Sponsor
University of Oxford
Target Recruit Count
360
Registration Number
NCT01066182
Locations
🇬🇧

Department of Social Policy and Social Work, Oxford, Oxfordshire, United Kingdom

Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy

Phase 3
Completed
Conditions
Malaria
Interventions
First Posted Date
2010-01-22
Last Posted Date
2022-03-25
Lead Sponsor
University of Oxford
Target Recruit Count
511
Registration Number
NCT01054248
Locations
🇹🇭

Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Completed
Conditions
Metastatic Colorectal Cancer
Metastatic Breast Cancer
First Posted Date
2010-01-21
Last Posted Date
2012-07-25
Lead Sponsor
University of Oxford
Target Recruit Count
26
Registration Number
NCT01053104
Locations
🇬🇧

Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom

Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
Drug: Placebo
First Posted Date
2010-01-11
Last Posted Date
2010-01-11
Lead Sponsor
University of Oxford
Target Recruit Count
134
Registration Number
NCT01046032
Locations
🇬🇧

IVF Hammersmith, London, United Kingdom

🇬🇧

Nuture IVF Unit, Nottingham, United Kingdom

🇬🇧

Oxford Fertility Unit, Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath